Trials / Completed
CompletedNCT01013909
Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs Placebo
An Investigator-blind, Randomized, Multicenter, 5-arm, Placebo- and Active Controlled Parallel Group Pilot Trial to Explore the Efficacy and Tolerability of Topical Bifonazole Liquid Spray in Patients With Athlete's Foot.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 220 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The study shall prove whether 6 consecutive doses of Bifonazole spray show comparable efficacy to a Terbinafine solution applied once.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bifonazole spray once daily | Application of one dose daily by means of an metered dose |
| DRUG | Bifonazole spray twice daily | Application of two dose daily by means of an metered dose |
| DRUG | Placebo | Application of one dose daily by means of an metered dose |
| DRUG | Placebo | Application of one dose daily by means of an metered dose |
| DRUG | Lamisil Once | One application of Lamisil Once |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2009-11-16
- Last updated
- 2015-01-27
Locations
4 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01013909. Inclusion in this directory is not an endorsement.